₹ 3.02
-0.13 (-4.13%)
BSE
T
Transgene Biotek
₹ 3.02
BSE
TRABI Fundamentals
Company Valuation
Market Cap (₹ Cr.)
23
PE Ratio
-12.60
PB Ratio
-2.85
Dividend Yield
-
ROE
-6.74%
ROCE
-0.33%
Book Value (₹)
-1.10
Face Value (₹)
10.00
Analyse TRABI with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 71.88% | 71.89% | 71.85% | 71.85% | 71.81% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
TRABI Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare Services
Sub Sector
Healthcare Service Provider
Company Classification
Microcap
BSE Scrip Code
526139
NSE Scrip Name
TRABI
ISIN
INE773D01018



